Document is current

Any future updates will be listed below

Genetic subtype-guided immunochemotherapy in relapsed and refractory diffuse large B cell lymphoma: a phase 2 investigator-initiated nonrandomized clinical trial (GUIDANCE-06)

Crossref DOI link: https://doi.org/10.1038/s41392-025-02316-6

Published Online: 2025-07-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark